Last reviewed · How we verify
NCT02936973
Catgut Implantation at Acupoints for the Treatment of Simple Obesity
NA trial testing Real catgut implantation at acupoints in Obesity in 216 participants. Completed in 15 May 2018.
15 May 2018
Quick facts
| Lead sponsor | Hubei Hospital of Traditional Chinese Medicine |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 216 |
| Start date | 15 February 2017 |
| Primary completion | 15 May 2018 |
| Estimated completion | 15 May 2018 |
| Sites | 1 location across China |
Drugs / interventions tested
- Real catgut implantation at acupoints
- sham catgut implantation at acupoints
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
Hubei Hospital of Traditional Chinese Medicine
Who can join
Adults 18 to 45, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this multicenter randomized controlled trial is to evaluate treatment effectiveness of intervening simple obesity people with catgut implantation at preferred acupoints, which excludes placebo effect; the secondary objective is to evaluate safety and superiority of treating simple obesity with catgut implantation at acupoints to provide high-level evidence for it clinically.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effect of Acupoint Catgut Embedding for Middle-Aged Obesity: A Multicentre, Randomised, Sham-Controlled Trial.
Chen X, Huang W, Wei D, Zhao JP, et al · · 2022 · cited 8× · PMID 35265146 · DOI 10.1155/2022/4780019 -
Clinical effect of catgut implantation at acupoints for the treatment of simple obesity: A multicentre randomized controlled trial.
Chen X, Huang W, Wei D, Ding DG, et al · · 2020 · cited 5× · PMID 33235115 · DOI 10.1097/md.0000000000023390
Verify or expand the search:
- PubMed search for NCT02936973
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Hubei Hospital of Traditional Chinese Medicine trials
Trials by the same sponsor.
- NCT07448090 — Real-World Registry Study of Integrated Traditional Chinese and Western Medicine for Obesity · recruiting
- NCT04957134 — Efficacy of Electro-acupuncture for Abdominal Obesity: Study for a Randomized Controlled Trial · NA · completed
- NCT04943705 — Evaluation of the Clinical Efficacy of Moxibustion With Regulating Yin and Yang in the Treatment of Menopausal Obesity · NA · unknown
- NCT04835181 — Electroacupuncture Combined With Umbilical Moxibustion on Abdominal Obesity of Yang Deficiency · NA · unknown
- NCT04606680 — Herb-partitioned Moxibustion Plus Lifestyle Modification Treatment for Simple Obesity · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02936973 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hubei Hospital of Traditional Chinese Medicine
- Last refreshed: 5 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02936973.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing